↓ Skip to main content

Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study

Overview of attention for article published in Frontiers in Pharmacology, June 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
50 X users
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
104 Dimensions

Readers on

mendeley
127 Mendeley